BRIEF published on 01/15/2026 at 11:50, 7 months 27 days ago Zürcher Kantonalbank's Disclosure on Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/15/2026 at 11:45, 7 months 27 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses ownership of 0.04% of Avadel Pharmaceuticals plc shares as of 14-Jan-2026, as per Form 8.3 filing with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Ownership Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/14/2026 at 14:35, 7 months 28 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Ordinary Shares Disclosure Irish Takeover Panel Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/14/2026 at 14:30, 7 months 28 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed 1.55% stake in Avadel Pharmaceuticals plc on 13th January 2026 Disclosure Irish Takeover Panel Stake Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/06/2026 at 12:50, 8 months 5 days ago Zürcher Kantonalbank Discloses Stake in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/06/2026 at 12:45, 8 months 5 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclose a 0.04% interest in Avadel Pharmaceuticals plc. Details of open stock-settled derivatives positions provided Disclosure Irish Takeover Panel Stock-settled Derivatives Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 20:35, 8 months 6 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Holding Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 20:30, 8 months 6 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank and subsidiaries disclosed a 1.02% interest in Avadel Pharmaceuticals plc shares on 2nd January 2026 Shares Disclosure Interests Zürcher Kantonalbank Avadel Pharmaceuticals Plc
BRIEF published on 01/05/2026 at 17:05, 8 months 6 days ago Zürcher Kantonalbank Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals
PRESS RELEASE published on 01/05/2026 at 17:00, 8 months 6 days ago Form 8.3 - Zürcher Kantonalbank: Avadel Pharmaceuticals plc Zürcher Kantonalbank discloses 1.02% position in Avadel Pharmaceuticals plc as of 31st December 2025 following dealing activities Position Disclosure Zürcher Kantonalbank Avadel Pharmaceuticals Plc 1.02% Dealing Activities
Published on 09/12/2026 at 02:35, 3 hours 58 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 7 hours 33 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 8 hours 28 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 9 hours 8 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 13 hours 33 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 8 hours 18 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 8 hours 23 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 10 hours 48 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 12 hours 18 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 23 hours 33 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 23 hours 33 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 11 hours ago Availability of the 2026 Interim Financial Report
